NEXTCURE INC. - COMMON STOCK

NextCure to Present at Upcoming Investor Conferences

22 Nov 2022 08:00:02 By Nasdaq GlobeNewswire

NextCure and LegoChem Biosciences Enter into Collaboration and Co-Development Agreement to Develop Antibody Drug Conjugates

15 Nov 2022 16:30:00 By Nasdaq GlobeNewswire

NextCure Presents Initial Data from Clinical Trial of NC762 and a Trial in Progress Poster for NC410 Combo at the 2022 Society for Immunotherapy of Cancer Annual Meeting

07 Nov 2022 08:05:00 By Nasdaq GlobeNewswire

NextCure Provides Update and Reports Third Quarter 2022 Financial Results

03 Nov 2022 16:15:00 By Nasdaq GlobeNewswire

NextCure to Present Trial in Progress Poster for NC525 at the 2022 American Society of Hematology (ASH) Annual Meeting

03 Nov 2022 09:15:00 By Nasdaq GlobeNewswire

NextCure Appoints Dr. Lisa M. Coussens to Scientific Advisory Board

27 Oct 2022 16:05:00 By Nasdaq GlobeNewswire

NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting

05 Oct 2022 08:15:00 By Nasdaq GlobeNewswire

NextCure Announces Initiation of Phase 1b/2 Clinical Trial to Evaluate NC410 in Combination with KEYTRUDA® (Pembrolizumab) in Patients with Immune Checkpoint Refractory or Naïve Solid Tumors

04 Oct 2022 16:05:00 By Nasdaq GlobeNewswire

NextCure to Present at the Ladenburg Thalmann Healthcare Conference

22 Sep 2022 08:00:01 By Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Second Quarter 2022 Financial Results

04 Aug 2022 16:05:01 By Nasdaq GlobeNewswire

NextCure Announces Development of a Highly Specific Immunohistochemical Diagnostic for Siglec-15-positive Tumors as reported in Laboratory Investigation

06 Jul 2022 08:00:01 By Nasdaq GlobeNewswire

NextCure Presented NC410 Data at the Extracellular Matrix (ECM) Pharmacology Congress in Europe on Overcoming Clinical Limitations to Immunotherapy Through Remodeling Tumor ECM

27 Jun 2022 08:00:01 By Nasdaq GlobeNewswire

Dr. Brahm Segal appointed to NextCure Scientific Advisory Board; NextCure and Roswell Park Shared Nonclinical Data on the Impact of NC410 Blockade on Neutrophil-mediated T Cell Suppression at the 24th Translational Research Cancer Centers Consortium Annual Meeting

22 Jun 2022 08:00:01 By Nasdaq GlobeNewswire

NextCure to Present at the JMP Securities Life Sciences Conference

08 Jun 2022 08:00:02 By Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports First Quarter 2022 Financial Results

05 May 2022 16:05:01 By Nasdaq GlobeNewswire

NextCure to Present at the BofA Securities 2022 Healthcare Conference

03 May 2022 08:00:02 By Nasdaq GlobeNewswire

NextCure and the National Cancer Institute Announce Preclinical Data in Journal of Clinical Investigation

19 Apr 2022 07:30:00 By Nasdaq GlobeNewswire

NextCure to Present at 21st Annual Needham Virtual Healthcare Conference

05 Apr 2022 08:00:02 By Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results

03 Mar 2022 16:05:01 By Nasdaq GlobeNewswire

NextCure to Present at 11th Annual SVB Leerink Global Healthcare Conference

08 Feb 2022 08:00:01 By Nasdaq GlobeNewswire